Candela
Formerly Syneron Medical, Candela Medical, Syneron-Candela
Medical Aesthetic Devices
Startup Acquired Health Tech & Life Sciences Est. 2000 Acquired
Total Raised
Undisclosed
Acquired
Last Round
Undisclosed
2 rounds
Investors
1
1 public
Team
2
500+ employees
Confidence
93/100
News
19
articles
Patents
1
About
Candela is an aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The company's technology enables physicians to provide advanced solutions for a broad range of medical aesthetic applications, including body contouring; hair removal; wrinkle reduction; tattoo removal; women's intimate wellness treatments; treatment of superficial benign vascular and pigmented lesions; and the treatment of acne, leg veins, and cellulite. Candela's portfolio of products includes UltraShape, VelaShape, GentleLase, VBeam Perfecta, PicoWay, CO2RE, CO2RE Intima, Profound, and els Plus.
Classification
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsPharma & Medical BiotechnologyCosmetic Materials
Core Technology
CommunicationsRadio Frequency
Target Customer
Healthcare & Life SciencesHealthcareProvidersPatientsLife SciencesCosmeticsConsumersCommerce & RetailDistribution ChannelsDistributor
Business Model
B2BB2C
Tags
dermatologynon-invasivemedical-devicescosmeticsskin-careclinicsacnenon-surgicalhospitalsdoctorshealthcare-providerstreatmentsconsumersoptronicsmedical-technologies
Funding & Events
Sep 2018
M&A Undisclosed
Nov 2015
M&A $3.2M
Jul 2017
Exit Undisclosed
Jul 2017
Exit $397M
Jan 2002
Seed Undisclosed
Israel HealthCare Ventures (Lead)
Aug 2004
Exit Undisclosed
News (19)
Apr 22, 2025 · www.prnewswire.com
growth-positive
/PRNewswire/ -- Sapiens International Corporation (NASDAQ: SPNS) (TASE: SPNS), a global leader in intelligent insurance software solutions today announced the...
AcquisitionCustomersPartners
Oct 28, 2022 · www.renaissancecapital.com
growth-negative
Aesthetic device maker Candela Medical postpones $250 million IPO
Public Trading
Oct 4, 2021 · www.globes.co.il
growth-positive
4 שנים לאחר שנמחקה: אייפקס מחזירה את סינרון-קנדלה לנאסד"ק
Public TradingManagement Changes
Jan 25, 2021 · www.prnewswire.com
growth-positive
Candela announces the launch of the Frax Pro™ system, the smart way to Frax
CustomersPartners
Jan 14, 2021 · www.medestheticsmag.com
growth-positive
Merz Aesthetics and Candela Corporation Launch Commercial Collaboration
CustomersPartners
Jun 17, 2020 · www.prnewswire.com
growth-positive
Candela Announces Health Canada Approval Of Two New Gynecological Indications For CO2RE® Laser Platform
Customers
Jan 31, 2020 · www.prnewswire.com
growth-positive
Candela® And MT.DERM Sign Exclusive Collaboration Agreement
Partners
Mar 20, 2019 · www.prnewswire.com
growth-positive
Candela and InMode Announce Settlement Of Patent Infringement Lawsuit
Partners
Mar 7, 2019 · www.medestheticsmag.com
growth-positive
Syneron-Candela Is Now Candela
Partners
Nov 7, 2018 · www.prnewswire.com
growth-negative
Syneron Candela Announces Updates In Patent Infringement Cases
CustomersPartners
Oct 1, 2018 · www.prnewswire.com
growth-positive
Syneron Candela Announces Launch of Direct Operation in Korea
Customers
Sep 5, 2018 · www.prnewswire.com
Syneron Candela Announces Acquisition Of Ellipse
Jul 18, 2018 · www.massdevice.com
growth-positive
Syneron Candela wins FDA nod for Vbeam Prima cosmetic laser
CustomersAcquisition
Jul 17, 2017 · www.prnewswire.com
growth-positive
Syneron Candela Completes Previously Announced Transaction with Funds Advised by Apax Partners and Becomes a Private Company
Acquisition
Jun 15, 2017 · www.prnewswire.com
growth-positive
Syneron Candela Announces Shareholder Approval of Proposed Acquisition by Funds Advised by Apax Partners
Acquisition
Apr 3, 2017 · www.globes.co.il
growth-positive
Apax confirms Syneron acquisition for $397m
Acquisition
Apr 2, 2017 · www.globes.co.il
growth-positive
Apax buying Syneron for $400-500m
Acquisition
growth-positive
Syneron Medical and Unilever Join Forces for "Iluminage Beauty" - Plastic Surgery Practice
Partners
Oct 19, 2005 · www.haaretz.co.il
growth-positive
בעלת מניות חדשה ויוקרתית בסינרון: פידליטי הגיעה לאחזקה של 5.6%
InvestmentPublic Trading
Details
Product Stage
Released
Employees
500+
Exact Count
611
District
North District
Founded
2000
Registrar
512986514
Crunchbase
syneron-medical
Locations
Yokneam Illit, Israel
3 Goodyear, Unit A Irvine 92618 United States
530 Boston Post Road, Wayland, MA 01778, United States
Links
Website
LinkedIn
Twitter
Facebook
Careers
Admin
Last Update
Nov 5, 2024
Verified by
Sharon Shapira
Missing
markets, not claimed
Team (2)
Geoffrey Crouse
CEO
Tuvya Klughaupt
General Manager
Internal
Created by
Tamar Weiss (tamar.e.weiss@gmail.com)
Created
2014-08-03T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)
Status
Acquired by Apax Partners on Jul, 2017